Checkpoint Therapeutics Stock
Price
Target price
-
-
-
-
-
?31.14
WKN: A2JAHK / Symbol: CKPT / Name: Checkpoint Therapeutics / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Checkpoint Therapeutics Stock
Checkpoint Therapeutics is currently one of the favorites of our community with 6 Buy predictions and no Sell predictions.
With a target price of 31 € there is potential for a 6085.16% increase which would mean more than doubling the current price of 0.5 € for Checkpoint Therapeutics.
Pros and Cons of Checkpoint Therapeutics in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
B****
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Checkpoint Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Checkpoint Therapeutics | - | - | - | - | - | - | - |
| Evolus Inc | 2.940% | 16.667% | 21.739% | 64.706% | 54.696% | 51.351% | - |
| Ardelyx Inc. | 5.770% | 6.941% | 7.836% | 67.751% | -1.903% | 364.754% | 79.034% |
| Coherus Bioscien. | 4.560% | 8.696% | -18.879% | -71.053% | -59.293% | -90.553% | -93.737% |
Comments
Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) had its price target lowered by analysts at HC Wainwright from $34.00 to $20.00. They now have a "buy" rating on the stock.
Show more
Ratings data for CKPT provided by MarketBeat
Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $34.00 price target on the stock.
Show more
Ratings data for CKPT provided by MarketBeat
Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $34.00 price target on the stock.
Show more
Ratings data for CKPT provided by MarketBeat